Reagan-Udall Foundation for the FDA

Reagan-Udall Foundation for the FDA We're the FDA's foundation: a nonprofit, created by Congress, helping to modernize regulatory science. We're on it. And you can join us.

What better way to say nonpartisan than for Congress to name us after Ronald Reagan and Mo Udall? Back in 2007 the call to action was to identify, fund, and support projects and programs that help equip FDA staff with the highest caliber science and technology. For example, you can share our newly launched expanded access Navigator website with patients and physicians researching the complexities of compassionate use. Or if you're a company, list your expanded access policies on the Navigator's Directory or check out our IMEDS public-private partnerships. Other ways to help us help FDA include donations to our Fellowship program or joining us at the first-ever "Innovations in Regulatory Science" Gala. It's all on our site www.reaganudall.org.

02/12/2026

Highlighting the Reagan-Udall Foundation for the FDA and its impact on rare disease research and clinical trials.

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational dr...
02/09/2026

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational drugs — to see if Expanded Access may be an option for you or a loved one: https://navigator.reaganudall.org

Just under three weeks away!On February 26, we’ll host a hybrid public meeting on Advancing Drug Development by Reducing...
02/06/2026

Just under three weeks away!

On February 26, we’ll host a hybrid public meeting on Advancing Drug Development by Reducing Reliance on Animal Testing.

This discussion will bring together experts from academia, the research community, regulators, and regulated industry to examine challenges associated with animal-based safety assessments and explore human-relevant alternatives—including U.S. Food and Drug Administration-supported New Approach Methodologies. Using inhalation toxicology as a case study, the meeting will also explore opportunities to better align global regulatory expectations.

You don't want to miss this important conversation. Register today: https://reaganudall.org/news-and-events/events/advancing-drug-development-reducing-reliance-animal-testing

At-home diagnostic tests have become an essential part of modern health care, empowering consumers with faster, more con...
02/03/2026

At-home diagnostic tests have become an essential part of modern health care, empowering consumers with faster, more convenient access to information about their health. While advances in over-the-counter diagnostics can empower patients and accelerate care, uncertainty around regulatory processes, market access, and reimbursement can slow innovation.

Join us for a hybrid public meeting focused on over-the-counter diagnostics. We’ll bring together stakeholders to explore gaps, foster collaboration, and identify pathways to support the development, review and deployment of at-home diagnostic devices—advancing the home as a hub of health care. Register today: https://reaganudall.org/news-and-events/events/over-counter-diagnostics-advancing-home-health-care-hub

In December 2025, we brought together industry stakeholders, consumer representatives, and U.S. Food and Drug Administra...
01/30/2026

In December 2025, we brought together industry stakeholders, consumer representatives, and U.S. Food and Drug Administration observers for a roundtable on nutrition and food rating systems.

The discussion explored voluntary, private sector opportunities to define shared values and strengthen consistency across rating systems. Our new topline summary report highlights key learnings on aligning around common principles and outlines considerations to guide future dialogue.

Read the summary report:https://reaganudall.org/sites/default/files/2026-01/Nutrition-Incentive-Roundtable-Top-Takeaways-Final.pdf

This afternoon, Foundation Research Director Dr. Carla Rodriguez-Watson will participate in a DrugInfoAssn Global Pharma...
01/27/2026

This afternoon, Foundation Research Director Dr. Carla Rodriguez-Watson will participate in a DrugInfoAssn Global Pharmacovigilance and Risk Management Strategies Conference panel covering What's New In Advancing Signal Detection?: Smarter Tools for Safety Evaluation.

During the panel, Dr. Rodriguez-Watson will discuss how the Innovation in Medical Evidence and Development Surveillance (IMEDS) program leverages Sentinel capabilities for safety evaluations.

Learn more about the IMEDS program: https://reaganudall.org/projects/research/imeds

We invite you to join our hybrid public meeting on February 26 focused on Advancing Drug Development by Reducing Relianc...
01/23/2026

We invite you to join our hybrid public meeting on February 26 focused on Advancing Drug Development by Reducing Reliance on Animal Testing.

This meeting will bring together academics, researchers, regulators, and regulated industry to examine how reliance on animal-based safety assessments can impact both medication innovation and patient outcomes. Using inhalation toxicology as a case study, speakers will explore practical, human-relevant alternatives, including U.S. Food and Drug Administration-supported New Approach Methodologies (NAMs), and opportunities to better align global regulatory expectations.

Register today to participate in person or virtually: https://reaganudall.org/news-and-events/events/advancing-drug-development-reducing-reliance-animal-testing

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational dr...
01/22/2026

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational drugs — to see if Expanded Access may be an option for you or a loved one: https://navigator.reaganudall.org

Address

1333 New Hampshire Avenue NW Suite 420
Washington D.C., DC
20036

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Reagan-Udall Foundation for the FDA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Reagan-Udall Foundation for the FDA:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram